BRD9 is an essential regulator of glycolysis that creates an epigenetic vulnerability in colon adenocarcinoma

BACKGROUND: The intensive interplay between aberrant epigenetic events and metabolic remodeling represents one of the hallmarks of tumors, including colon cancer. The functions of Bromodomain Containing Protein BRD‐9 in colon cancer remains indefinite. We aimed to identify the biological roles and c...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Qunshan, Gu, Xiang, Wei, Wei, Wu, Zheng, Gong, Fengqin, Dong, Xiaoqiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
RESEARCH ARTICLES
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9883419/
https://www.ncbi.nlm.nih.gov/pubmed/35778964
http://dx.doi.org/10.1002/cam4.4954

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9883419/
https://www.ncbi.nlm.nih.gov/pubmed/35778964
http://dx.doi.org/10.1002/cam4.4954

Ejemplares similares